Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13

Stock Information for LightPath Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About LightPath Technologies Inc.

Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Capricor Therapeutics to Present at Upcoming Investor Conferences
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.